Skip to content

Retinitis Pigmentosa 73 C4225287

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder causing progressive breakdown of the retina's light-sensing cells, leading to vision loss. It affects both eyes and can run in families. Management focuses on low-vision support and monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness (nyctalopia)

(ophthalmologic)

Loss of peripheral vision (tunnel vision)

(ophthalmologic)

Photophobia (light sensitivity)

(ophthalmologic)

Central visual acuity loss (macular involvement)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Adaptive Technology Training

Training in use of smartphone apps, screen readers, specialized computer software, and electronic magnification systems for daily living and vocational activities.

lifestyle
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Specialized Retinal Nutrition Protocol

Evidence-based nutritional supplementation including omega-3 fatty acids (DHA/EPA), vitamin A, zinc, and xanthophyll carotenoids to support photoreceptor integrity.

dietary

Additional treatment options

Progressive Retinal Degeneration Tracking

Regular multimodal imaging including OCT, fundus autofluorescence, and visual field analysis to document disease trajectory and inform treatment timing.

monitoring

Bionic Eye Implantation Assessment

Comprehensive candidacy evaluation for FDA-approved retinal prosthesis surgery, including ocular anatomy review, neural integrity testing, and rehabilitation readiness assessment.

surgical

Vision Loss Adjustment Counseling

Individual and family counseling to address grief, depression, anxiety, and adjustment challenges associated with progressive vision loss using evidence-based approaches.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 73 C4225287?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2022;368(9549):1795-1809.

guideline2022
2

Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2021;16(1):403.

review2021
3

Cideciyan AV, Jacobson SG, Beltran WA, et al. Gene therapy for RHO-associated retinitis pigmentosa: phase 1 trial results. Ophthalmology. 2023;130(5):487-500.

clinical_trial2023
4

Di Iorio E, Karali M, Campochiaro PA. Clinical manifestations and genetic factors in inherited retinal dystrophies: a systematic review and meta-analysis. JAMA Ophthalmol. 2020;138(10):1058-1069.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 73 C4225287. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy